DHODH and leukemia: In ER-homeobox (HOX) A9–transduced primary murine bone marrow cells, terminal differentiation occurs following β-estradiol withdrawal. Through a phenotypic screen using this model, DHODH inhibitors were found to bypass the differentiation block, reduce leukemia-initiating cells, decrease leukemic burden, and enhance survival.